|
BLM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.933200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.372600E-01 |
| Normal-vs-Stage2 |
1.283360E-01 |
| Normal-vs-Stage3 |
7.565800E-01 |
| Normal-vs-Stage4 |
7.666600E-01 |
| Stage1-vs-Stage2 |
4.17750000036854E-07 |
| Stage1-vs-Stage3 |
2.974400E-01 |
| Stage1-vs-Stage4 |
4.421200E-01 |
| Stage2-vs-Stage3 |
2.366700E-04 |
| Stage2-vs-Stage4 |
2.481200E-03 |
| Stage3-vs-Stage4 |
9.952400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.766400E-01 |
| Normal-vs-AfricanAmerican |
7.921200E-01 |
| Normal-vs-Asian |
5.388000E-01 |
| Caucasian-vs-AfricanAmerican |
2.038400E-01 |
| Caucasian-vs-Asian |
9.089400E-01 |
| AfricanAmerican-vs-Asian |
2.078200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.357000E-01 |
| Normal-vs-Female |
8.674000E-01 |
| Male-vs-Female |
3.275600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.842800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.668000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.308800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.472600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.778800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.361200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.238030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.479000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.451900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.024210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.580800E-01 |
| Classical-VS-Follicular |
1.78630000013946E-07 |
| Classical-VS-Other |
7.949600E-01 |
| Classical-VS-Normal |
3.869400E-01 |
| Tall-VS-Follicular |
7.029700E-04 |
| Tall-VS-Other |
6.590600E-01 |
| Tall-VS-Normal |
3.424800E-01 |
| Follicular-VS-Other |
1.400360E-01 |
| Follicular-VS-Normal |
1.812600E-01 |
| Other-VS-Normal |
7.114400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.314000E-01 |
| Normal-vs-N1 |
6.209200E-01 |
| N0-vs-N1 |
3.907200E-01 |
|
|
